Patents by Inventor Gary S. Elliott

Gary S. Elliott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9097729
    Abstract: The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr.
    Type: Grant
    Filed: July 26, 2011
    Date of Patent: August 4, 2015
    Assignee: AMGEN INC.
    Inventors: Daniel J. Freeman, Jilin Sun, Kenneth H. Jung, Gary S. Elliott, Robert Radinsky
  • Publication number: 20150051091
    Abstract: The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr.
    Type: Application
    Filed: July 26, 2011
    Publication date: February 19, 2015
    Inventors: Daniel J. Freeman, Jilin Sun, Kenneth H. Jung, Gary S. Elliott, Robert Radinsky
  • Publication number: 20140037635
    Abstract: Novel IL-17 like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing IL-17 like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with IL-17 like polypeptides, agonists, or antagonists thereof.
    Type: Application
    Filed: June 26, 2013
    Publication date: February 6, 2014
    Applicant: Amgen Inc.
    Inventors: Eugene MEDLOCK, Gary S. ELLIOTT, Shuqian JING, Scott Michael SILBIGER, Hung Q. NGUYEN, Richard YEH
  • Patent number: 7985559
    Abstract: The present application relates to methods of selecting EGFr binding agents. In certain embodiments, such EGFr binding agents bind to at least a portion of a panitumumab epitope on an EGFr. In certain embodiments, such EGFr binding agents do not bind to a panitumumab epitope on an EGFr.
    Type: Grant
    Filed: October 17, 2008
    Date of Patent: July 26, 2011
    Assignee: AMGEN Inc.
    Inventors: Daniel J. Freeman, Jilin Sun, Kenneth H. Jung, Gary S. Elliott, Robert Radinsky
  • Publication number: 20110160438
    Abstract: The present invention provides for IL-17 receptor like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, agonists and antagonists (including selective binding agents), and methods for producing IL-17 receptor like polypeptides. Also provided for are methods for treatment, diagnosis, amelioration, or prevention of diseases with IL-17 receptor like polypeptides.
    Type: Application
    Filed: October 28, 2010
    Publication date: June 30, 2011
    Applicant: Amgen Inc.
    Inventors: Eugene Medlock, Richard Yeh, Scott M. Silbiger, Gary S. Elliott, Hung Q. Nguyen, Shuqian Jing
  • Patent number: 7943738
    Abstract: The present invention provides for IL-17 receptor like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, agonists and antagonists (including selective binding agents), and methods for producing IL-17 receptor like polypeptides. Also provided for are methods for treatment, diagnosis, amelioration, or prevention of diseases with IL-17 receptor like polypeptides.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: May 17, 2011
    Assignee: Amgen Inc.
    Inventors: Eugene Medlock, Richard Yeh, Scott Michael Sibiger, Gary S. Elliott, Hung Q. Nquyen, Shuqian Jing
  • Publication number: 20100303820
    Abstract: Novel IL-17 like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing IL-17 like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with IL-17 like polypeptides, agonists, or antagonists thereof.
    Type: Application
    Filed: May 25, 2010
    Publication date: December 2, 2010
    Applicant: Amgen Inc.
    Inventors: Eugene Medlock, Richard Yeh, Scott Michael Silbiger, Gary S. Elliott, Hung Q. Nguyen, Shuqian Jing
  • Publication number: 20090281287
    Abstract: The present invention provides for IL-17 receptor like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, agonists and antagonists (including selective binding agents), and methods for producing IL-17 receptor like polypeptides. Also provided for are methods for treatment, diagnosis, amelioration, or prevention of diseases with IL-17 receptor like polypeptides.
    Type: Application
    Filed: June 3, 2009
    Publication date: November 12, 2009
    Applicant: Amgen Inc.
    Inventors: Eugene Medlock, Richard Yeh, Scott M. Silbiger, Gary S. Elliott, Hung Q. Nguyen, Shuqian Jing
  • Patent number: 7611857
    Abstract: The present invention provides for IL-17 receptor like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, agonists and antagonists (including selective binding agents), and methods for producing IL-17 receptor like polypeptides. Also provided for are methods for treatment, diagnosis, amelioration, or prevention of diseases with IL-17 receptor like polypeptides.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: November 3, 2009
    Assignee: Amgen Inc.
    Inventors: Eugene Medlock, Richard Yeh, Scott Michael Silbiger, Gary S. Elliott, Hung Q. Nquyen, Shuqian Jing
  • Patent number: 7094566
    Abstract: The present invention provides for IL-17 receptor like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, agonists and antagonists (including selective binding agents), and methods for producing IL-17 receptor like polypeptides. Also provided for are methods for treatment, diagnosis, amelioration, or prevention of diseases with IL-17 receptor like polypeptides.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: August 22, 2006
    Assignee: Amgen Inc.,
    Inventors: Eugene Medlock, Richard Yeh, Scott M. Silbiger, Gary S. Elliott, Hung Q. Nguyen, Shuqian Jing
  • Patent number: 7041796
    Abstract: Novel C3b/C4b CR-like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing C3b/C4b CR-like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with C3b/C4b CR-like polypeptides.
    Type: Grant
    Filed: May 16, 2002
    Date of Patent: May 9, 2006
    Assignee: Amgen Inc.
    Inventors: Andrew A. Welcher, Gary S. Elliott
  • Patent number: 6656707
    Abstract: Novel C3b/C4b CR-like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing C3b/C4b CR-like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with C3b/C4b CR-like polypeptides.
    Type: Grant
    Filed: July 24, 2001
    Date of Patent: December 2, 2003
    Assignee: Amgen Inc.
    Inventors: Andrew A. Welcher, Gary S. Elliott
  • Publication number: 20020192758
    Abstract: Novel C3b/C4b CR-like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing C3b/C4b CR-like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with C3b/C4b CR-like polypeptides.
    Type: Application
    Filed: May 16, 2002
    Publication date: December 19, 2002
    Inventors: Andrew A. Welcher, Gary S. Elliott
  • Publication number: 20020151483
    Abstract: Novel C3b/C4b CR-like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing C3b/C4b CR-like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with C3b/C4b CR-like polypeptides.
    Type: Application
    Filed: July 24, 2001
    Publication date: October 17, 2002
    Inventors: Andrew A. Welcher, Gary S. Elliott
  • Publication number: 20020037524
    Abstract: Novel IL-17 like polypeptides and nucleic acid molecules encoding the same. The invention also provides vectors, host cells, selective binding agents, and methods for producing IL-17 like polypeptides. Also provided for are methods for the treatment, diagnosis, amelioration, or prevention of diseases with IL-17 like polypeptides, agonists, or antagonists thereof.
    Type: Application
    Filed: June 21, 2001
    Publication date: March 28, 2002
    Inventors: Eugene Medlock, Richard Yeh, Scott M. Silbiger, Gary S. Elliott, Hung Q. Nguyen, Shuqian Jing
  • Patent number: 4350444
    Abstract: An apparatus for mixing materials is disclosed. The apparatus includes a hopper, a substantially vertical auger within the hopper, and a housing enclosing the auger to define a mixing chamber. A baffle, attached to the housing, and the sidewall of the hopper are oriented so as to cooperatively provide a blending flow pattern within the hopper, thereby further mixing the materials.
    Type: Grant
    Filed: November 12, 1980
    Date of Patent: September 21, 1982
    Assignees: Lloyd A. Yargus, Larry D. Yargus
    Inventors: Lloyd A. Yargus, Lester W. Switzer, Sr., Gary N. Allen, Gary S. Elliott, Larry D. Yargus, William D. Lowry, Jeffrey M. Gosnell, Darrell J. Spires